Journal of Clinical Epidemiology
Volume 63, Issue 3 , Pages 331-341 , March 2010

Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions

,Accepted 9 June 2009.

References 

  1. In:  Gold MR,  Russell LB,  Weinstein MC editor. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;
  2. Miller W, Robinson LA, Lawrence RS. Valuing health for regulatory analysis. Washington, DC: The National Academies Press; 2006;
  3. Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006;9:213–218
  4. Bolen J, Sniezek J, Theis K, Helmick C, Hootman J, Brady T, et al. Racial/ethnic differences in the prevalence and impact of doctor-diagnosed arthritis—United States, 2002. MMWR Morb Mortal Wkly Rep. 2005;54:119–123
  5. Thrall JH. Prevalence and costs of chronic disease in a health care system structured for treatment of acute illness. Radiology. 2005;235:9–12
  6. Centers for Disease Control and Prevention. Healthy aging: preventing disease and improving quality of life among older Americans. 2007. Available at http://www.cdc.gov/nccdphp/publications/aag/aging.htm. Accessed July 2008.
  7. Wu S, Green A. Projection of chronic illness prevalence and cost inflation. Santa Monica, CA: RAND Health; 2000;
  8. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, et al. The Beaver Dam Health Outcomes study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89–102
  9. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998;36:778–792
  10. Mitmann N, Trakas K, Risebrough N, Lie BA. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics. 1999;15:369–376
  11. Ko Y, Coons SJ. Self-reported chronic conditions and EQ-5D index scores in the US adult population. Curr Med Res Opin. 2006;22:2065–2071
  12. Saarni SL, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res. 2006;15:1403–1414
  13. Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43:736–749
  14. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26:410–420
  15. Flanagan W, McIntosh CN, Le Petit C, Berthelot JM. Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores. Popul Health Metr. 2006;4:13;Available at http://www.pophealthmetrics.com/content/4/1/13 Accessed June 2007
  16. van Baal PHM, Hoeymans N, Hoogenveen RT, de Wit GA, Westert GP. Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr. 2006;4:1;Available at http://www.pophealthmetrics.com/content/4/1/1 Accessed June 2007
  17. Dale W, Basu A, Elstein A, Meltzer D. Predicting utility ratings for joint health states from single health states in prostate cancer: empirical testing of three alternative theories. Med Decis Making. 2008;28:102–112
  18. Gold MR, Stevenson D, Fryback DG. HALYs and QALYs and DALYs, Oh My: similarities and differences in summary measures of population health. Annu Rev Public Health. 2002;23:115–134
  19. Jones N, Jones SL, Miller NA. The Medicare Health Outcomes Survey program: overview, context, and near-term prospects. Health Qual Life Outcomes. 2004;2:33;Available at http://www.hqlo.com/content/2/1/33 Accessed June 2007
  20. Ware JE, Snow KK, Kosinski M, Gandek M. SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993;
  21. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292
  22. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859
  23. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325–337
  24. Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A. Bayesian measures of model complexity and fit (with discussion). J R Stat Soc B. 2002;64:583–616
  25. Center for the Evaluation of Value and Risk in Health. The cost-effectiveness analysis registry [internet]. (Boston, MA), Institute for Clinical Research and Health Policy Studies, Tufts Medical Center. Available at : http://www.cearegistry.org Accessed May 2009.
  26. Cohen JW, Monheit AC, Beauregard KM, Cohen SB, Lefkowitz DC, Potter DE, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996–1997;33:373–389Winter
  27. Beland Y. Canadian community health survey—methodological overview. Health Rep. 2002;13:9–14
  28. Walter SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1:4;Available at http://www.hqlo.com/content/1/1/4 Accessed June 2007
  29. Walter SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532
  30. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40:171–178

PII: S0895-4356(09)00220-0

doi: 10.1016/j.jclinepi.2009.06.013

Journal of Clinical Epidemiology
Volume 63, Issue 3 , Pages 331-341 , March 2010

Article Tools

* Image Usage & Resolution